SOLARA ACTIVE PHARMA SCIENCES
|
The Current P/B Ratio of SOLARA ACTIVE PHARMA SCIENCES is 3.27.
Share Price | ₹633.3 | Jan 13,2025 |
Market Cap | ₹3,045.9 Cr | |
Book Value | ₹932.3 Cr | Mar2024 - Consolidated Results |
Price/Book | 3.27x | Calculated as MarketCap/Book Value |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PB (Price/Book ) ratio of SOLARA ACTIVE PHARMA SCIENCES
P/B =
Market Capitalization
/ Book Value
or, using per-share numbers:
P/B = Stock Price /
Book Value Per Share
Current Market Cap [ ₹3,045.9 Cr] as on Jan 13,2025
(/) Book Value [ ₹932.3 Cr] based on Mar2024 - Consolidated Results
(=) P/B Ratio [ 3.27x ]
Thus, for SOLARA ACTIVE PHARMA SCIENCES , the investors are currently willing to pay '3.27 times book value' to own 1 share of the company.
PB Multiples are one of the most widely used valuation multiple in industry.
Since P/B ratio uses Book Value in the calculation, P/B multiples are not always reliable for valuing companies with negative book value.
In such cases, you may consider using Price to Earnings ratio or Price to Sales ratio of SOLARA ACTIVE PHARMA SCIENCES !
The chart below summarizes the trend in P/B Ratio of SOLARA ACTIVE PHARMA SCIENCES over the last five years.
Historical PB (Price/Book ) ratio chart of SOLARA ACTIVE PHARMA SCIENCES
PB Ratio Performance Analysis for SOLARA ACTIVE PHARMA SCIENCES
- SOLARA ACTIVE PHARMA SCIENCES 's p/b ratio for fiscal years ending Mar2024 to Mar2020 averaged 1.63x.
- SOLARA ACTIVE PHARMA SCIENCES 's operated at median p/b ratio of 1.44x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, SOLARA ACTIVE PHARMA SCIENCES 's p/b ratio peaked in Mar2021 at 3.16x.
- SOLARA ACTIVE PHARMA SCIENCES 's p/b ratio hit its five-year low in Mar2023 of 0.79x.
How does SOLARA ACTIVE PHARMA SCIENCES 's P/B Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Book Value | PB Ratio | Market Cap |
---|---|---|---|
SOLARA ACTIVE PHARMA SCIENCES | 932.26 | 3.27 | 3,045.9 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 63,666.80 | 6.58 | 418,936.0 |
CIPLA LTD | 26,619.90 | 4.37 | 116,200.0 |
DR REDDYS LABORATORIES LTD | 28,123.50 | 3.96 | 111,325.0 |
ZYDUS LIFESCIENCES LTD | 19,829.50 | 4.94 | 98,037.4 |
DIVIS LABORATORIES LTD | 13,571.00 | 11.21 | 152,157.0 |
MANKIND PHARMA LTD | 9,339.84 | 11.44 | 106,880.0 |
TORRENT PHARMACEUTICALS LTD | 6,856.15 | 15.99 | 109,617.0 |
LUPIN LTD | 14,175.80 | 6.93 | 98,275.2 |
AUROBINDO PHARMA LTD | 29,842.80 | 2.26 | 67,480.4 |
ABBOTT INDIA LTD | 3,658.73 | 16.58 | 60,664.8 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PB Analysis vs SOLARA ACTIVE PHARMA SCIENCES 's P/B Ratio
Top 10 Industry Peers | PB Ratio |
---|---|
Min industry PB | 2.26x |
Max industry PB | 16.58x |
Median industry PB | 6.58x |
Average industry PB | 7.96x |
You may also like the below Video Courses